AzTrials
AzTrials

Nutritional and Metabolic DiseaseNCT01729949

The Acute and Chronic Effects of Fruit Polyphenols on Chronic Disease (PPF)

A study testing Active Treatment Beverage in people with Nutritional and Metabolic Disease and Overweight, run by Clinical Nutrition Research Center, Illinois Institute of Technology at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

1. The primary objective is to determine the effect of fruit polyphenols on postprandial lipoprotein triglyceride metabolism after consumption a standard high carbohydrate/fat breakfast meal with a beverage rich in fruit-derived polyphenols compared to energy and macro-/micro-nutrient matched control beverage (acute… Read more about this study

Who is it for?
Ages 40 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Nutritional and Metabolic Disease, Overweight
What is being tested?
Active Treatment Beverage
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
34 participants
Where
1 siteUnited States
Study dates
1 Dec 2012to 26 Jun 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Non-smoking healthy overweight or class I obesity adult men and women
  • Age 40-65yr
  • Weight stable
  • Able to provide informed consent
  • Able to comply and perform the procedures requested by the protocol.

Who cannot join

  • Smokers or recent past smokers
  • Men or women with known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients
  • Diabetes
  • Fasting blood glucose concentrations >125 mg/dL
  • Fasting Total Cholesterol >250 mg/dL (6.47mmol/L)
  • Fasting Triglycerides >250 mg/dL (2.82 mmol/L)
Show all 17Show fewer
  • Fasting LDL cholesterol >180 mg/dL (4.66 mmol/L)
  • Uncontrolled blood pressure >140 mmHg/90 mmHg
  • Documented vascular disease
  • Cancer other than skin (non-melanoma) in previous 5 years
  • Lactating and/or pregnant
  • Taking medications or dietary supplements eg., antioxidant supplements, lipid lowering medication, blood pressure lowering medications.
  • Recent blood donors (within 3 months)
  • Vegans
  • Substance (alcohol or drug) abuser (within the last 2 years)
  • Participated in a chronic feeding or medication clinical trial in the last 3 months.
  • Excessive coffee and tea consumers (> 4 cups/d)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Clinical Nutrition Research Center

    Chicago, Illinois, 60616

Other trials in United States

About this study

Official title: A Randomized Placebo Controlled Trial to Test the Acute and Chronic Effects of Fruit Polyphenols on Postprandial Indices of Chronic Disease (PPF)

  1. The primary objective is to determine the effect of fruit polyphenols on postprandial lipoprotein triglyceride metabolism after consumption a standard high carbohydrate/fat breakfast meal with a beverage rich in fruit-derived polyphenols compared to energy and macro-/micro-nutrient matched control beverage (acute, Part 1).
  2. Secondary objectives are: 1)to assess the effects of consuming daily for 8 weeks (chronic, Part 2) a beverage rich in fruit polyphenols compared to an energy and macro-/micro- nutrient matched control beverage on fasting glucose, insulin, lipids and markers of oxidative stress; and 2) to assess the effects of these beverages on meal-related changes in metabolic and oxidative stress measures after 8 weeks daily consumption.
Read the detailed description

The study is a single-center, double-blinded, randomized, 2-part, 2-arm, 4-sequence, crossover study that incorporates both the acute and chronic evaluations of fruit polyphenols on metabolic indices and markers of oxidative stress.

A planned sample size of 30 overweight men and women will be recruited into the study. Subjects will be required to meet several inclusion and exclusion criteria, which will be assessed through online and clinic screening mechanisms, including questionnaires, blood analysis, and anthropometric measurements. Eligible subjects will be invited to participate in the study. Subjects will begin by completing a 7-day pre-study assessment of their usual dietary intake using 3-day food diary followed by washout of dietary polyphenols. Subjects will participate in 4, 6 h postprandial study days: 2 preceding the chronic intervention and 2 after 8 weeks each of active (fruit polyphenols) and placebo beverages. Subjects will be randomized on the first day of starting the acute and chronic study phases. Subjects will be asked to limit polyphenolic containing foods and beverages for 3 days prior to each 6 h postprandial study visit as well through the chronic dietary intervention. Subjects will be provided a standardized dinner meal pack on the day before each 6 h postprandial visit.

For each 6 h postprandial study visit, subjects will arrive fasted and follow procedures published by our lab previously. This includes: pre-study evaluation for compliance (fasting, dinner consumption, limited polyphenol intake) and readiness for study visit, catheter placement by registered nurse, fasting blood sample, consumption of high fat/carbohydrate meal accompanied by 1 of the two treatment beverages (active/fruit polyphenol or placebo beverage), subsequent blood sampling from catheter [ ~1 tablespoon (12ml)] at designated time points for 6 hours. Each postprandial study visit day will last approximately 7 hours and subjects will be required to remain at the Clinical Nutrition Research Center at the Illinois Institute of Technology main campus for the duration of the visit. The visit procedures are repeated twice ~ 1 week apart to accommodate subject testing with both beverages.

After completing both acute 6 h postprandial study visits, subjects will roll over to the chronic phase of the study and receive a 2nd randomization sequence for consuming the active or the placebo beverage daily for 8 weeks. Before crossing over to the alternative treatment beverage for another 8 weeks, subjects will have a 4-week break (wash out). Subjects will be counseled for a low polyphenolic diet throughout the study to consume the assigned beverage twice per day with lunch and evening meals (except during 4-week washout).

At the end of each week 8 treatment period, subjects will come to the research center for a 6 h postprandial study visit day: all procedures are identical on each postprandial study test visit with the exception that only the placebo beverage will be consumed with the breakfast.

Being tested
Active Treatment Beverage, Placebo Treatment Beverage
Keywords
Nutrition, Polyphenols, Berries, Overweight, Lipid Panels
Medical subject headings
Metabolic Diseases, Overweight

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Active Treatment BeverageDietary supplement

    Also called Active Comparator

    Strawberry and Blackcurrent extract

  • Placebo Treatment BeverageDietary supplement

    Also called Placebo Comparator

    without active components

Study groups in NCT01729949
Study groupRoleWhat they receive
Active Treatment BeverageActive comparatorStrawberry powder and Blackcurrent extract
Receives: Dietary Supplement: Active Treatment Beverage
Placebo Treatment BeveragePlacebo comparatorPlacebo Beverage
Receives: Dietary Supplement: Placebo Treatment Beverage

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in Plasma Triglycerides Concentrations

    Changes in Plasma Triglyceride concentrations during the acute phases (from 0 to 6 hrs) and over the chronic phase, assessed by iAUC

    Measured: Acute Postprandial (6 h) and chronic (8 week) fasting and postprandial (6 h)

Secondary outcomes (4)
  1. Changes in Plasma Lipid and Lipoprotein panels

    Changes in Lipids (panel) and lipoprotein particle size/density by nuclear magnetic resonance (NMR)

    Measured: Acute postprandial (6 h) and chronic (8 week) fasting and postprandial (6 h)

  2. Changes in insulin concentrations

    Changes in Plasma insulin concentrations during the acute phases (from 0 to 6 hrs) and over the chronic phase, assessed by iAUC, total AUC, Cmax and TMax

    Measured: Acute postprandial (6 h) and chronic (8 week) fasting and postprandial (6 h)

  3. Changes in LDL oxidation

    Changes in Plasma OxLDL concentrations during the acute phases (from 0 to 6 hrs) and over the chronic phase, assessed by iAUC, total AUC, and Cmax

    Measured: Acute postprandial (6 h) and chronic (8 week) fasting and postprandial (6 h)

  4. Changes in F2-isoprostane concentrations

    Changes in Plasma F2-isoprostane concentrations during the acute phases (from 0 to 6 hrs) and over the chronic phases assessed by iAUC, total AUC, Cmax and TMax

    Measured: Acute postprandial (6 h) and chronic (8 week) fasting and postprandial (6 h)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Nov 2012 (estimated)
  2. Study start1 Dec 2012
  3. Primary completion20 Mar 2014
  4. Study completion26 Jun 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
34 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01729949
Sponsor's protocol ID
PPF 2012-073
Status last verified
Jul 2021
First submitted
8 Nov 2012
Last updated
27 Jul 2021
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Active Treatment Beverage in people with Nutritional and Metabolic Disease and Overweight, run by Clinical Nutrition Research Center, Illinois Institute of Technology at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in Plasma Triglycerides Concentrations (time frame: Acute Postprandial (6 h) and chronic (8 week) fasting and postprandial (6 h)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jul 2021; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in